Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(67%)

Phase Distribution

Ph early_phase_1
1
33%
Ph phase_4
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 42 (66.7%)

Trials by Status

terminated267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_4

NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures

NCT04905563
terminatedphase_4

Post-operative Analgesia in Elective, Soft-tissue Hand Surgery

NCT02029235
completedearly_phase_1

NSAIDS Versus Opioids in Acute SER II Ankle Fractures

NCT02373254

Clinical Trials (3)

Showing 3 of 3 trials
NCT04905563Phase 4

NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures

Terminated
NCT02029235Phase 4

Post-operative Analgesia in Elective, Soft-tissue Hand Surgery

Terminated
NCT02373254Early Phase 1

NSAIDS Versus Opioids in Acute SER II Ankle Fractures

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3